In Dudley over the last 15 years we have used a variety of engagement strategies to work with primary care clinicians to address the premature mortality from hypertension related diseases
Advises NICE on the formulation of its guidance on the safety and efficacy of interventional procedures.
Advice on the use of Leukomed Sorbact for preventing surgical site infection (SSI) to aid local decision making
Technology appraisals are recommendations on the clinical and cost-effectiveness of medicines and treatments in the NHS.
Everything NICE has said assessing and managing melanoma in an interactive flowchart
A quick guide to NICE resources for social care
How we select the subjects for development into information, advice and guidance
Evidence-based recommendations on rucaparib (Rubraca) for relapsed platinum-sensitive ovarian, fallopian tube or primary peritoneal cancer that has responded to
Evidence-based recommendations on pentosan polysulfate sodium (Elmiron) for bladder pain syndrome in adults
Evidence-based recommendations on rapid tests for group A streptococcal (strep A) infections in people aged 5 and over with a sore throat
Evidence-based recommendations on point-of-care creatinine devices to assess kidney function before CT imaging with intravenous contrast
This agreement relates to: Tezacaftor and ivacaftor (Symkevi®) in combination with ivacaftor (kalydeco) for treating cystic fibrosis patients who are
As a public body, NICE is required to follow civil service principles on communicating during the lead up to the general election.
NICE recommendations on the use of highly specialised technologies are made by an independent advisory committee called the Highly Specialised...
Our tool to help you plan for and implement NICE guidance. View upcoming guidance and understand the impact of guidance on your resources. Previously known as the forward planner.
Outside interests of the NICE board
Find out more about quality standards advisory committee 3 members at NICE.
Find out more about the NICE Medical Technologies Advisory Committee members by reading their biographies. Professor Peter Groves Chair About
Formally endorses resources produced by external organisations that support the implementation of NICE guidance and the use of quality standards.
Everything NICE has said on recognising and managing ovarian cancer in an interactive flowchart
Everything NICE has said on urogenital conditions in an interactive flowchart
Everything NICE has said on reducing the risk of excess winter deaths and illness associated with cold homes in an interactive flowchart
Everything NICE has said on antibiotic prescribing for self-limiting respiratory tract and ear infections in primary care in an interactive flowchart
Patient access schemes and the NICE Patient Access Liaison Unit When assessing new drugs and treatments, NICE looks at the cost of the treatment and...
We've produced resources to support our social care guidelines and quality standards. The resources contain key messages and are designed to help you...
Everything NICE has said on cannabis-based medicinal products in an interactive flowchart.
Everything NICE has said on multiple sclerosis in an interactive flowchart
This guideline covers prescribing of cannabis-based medicinal products for people with intractable nausea and vomiting, chronic pain, spasticity and severe treatment-resistant epilepsy.
This guideline covers diagnosing and managing multiple sclerosis in people aged 18 and over. It aims to improve the quality of life for adults with multiple sclerosis by promoting symptom management, comprehensive reviews and effective relapse treatment.
Recommendation ID NG140/7 Question What is the optimal regimen for general anaesthesia for women having surgical abortion? Any explanatory
Recommendation ID NG140/5 Question What local anaesthetic techniques are most effective for women having surgical abortion? Any explanatory
Recommendation ID NG140/1 Question What is the optimal antibiotic prophylaxis regimen for women who are having a surgical abortion?
Recommendation ID NG140/3 Question Should women having a surgical abortion up to and including 10+0 weeks' gestation have anti-D prophylaxis